Literature DB >> 33398630

Xian-Ling-Gu-Bao protects osteoporosis through promoting osteoblast differentiation by targeting miR-100-5p/KDM6B/RUNX2 axis.

Liang Ai1,2, Weimin Yi2, Liudan Chen2, Haibin Wang3, Qihui Huang4.   

Abstract

Entities:  

Year:  2021        PMID： 33398630     DOI： 10.1007/s11626-020-00530-w

Source DB:  PubMed          Journal:  In Vitro Cell Dev Biol Anim        ISSN： 1071-2690            Impact factor:   2.416


× No keyword cloud information.
  3 in total

1.  MiRNA-27a-3p promotes osteogenic differentiation of human mesenchymal stem cells through targeting ATF3.

Authors:  Y-C Fu; S-R Zhao; B-H Zhu; S-S Guo; X-X Wang
Journal:  Eur Rev Med Pharmacol Sci       Date:  2019-08       Impact factor: 3.507

2.  MicroRNA‑100‑5p inhibits osteoclastogenesis and bone resorption by regulating fibroblast growth factor 21.

Authors:  Long Zhou; Han-Yi Song; Lin-Lin Gao; Li-Yu Yang; Shuai Mu; Qin Fu
Journal:  Int J Mol Med       Date:  2018-12-06       Impact factor: 4.101

3.  Prognostic value and prospective molecular mechanism of miR-100-5p in hepatocellular carcinoma: A comprehensive study based on 1,258 samples.

Authors:  Qing-Lin He; Shan-Yu Qin; Lin Tao; Hong-Jian Ning; Hai-Xing Jiang
Journal:  Oncol Lett       Date:  2019-10-04       Impact factor: 2.967
  3 in total
  3 in total

1.  Comparative Efficacy of Xianling Gubao Capsules in Improving Bone Mineral Density in Postmenopausal Osteoporosis: A Network Meta-Analysis.

Authors:  Ming-Hui Luo; Jin-Long Zhao; Nan-Jun Xu; Xiao Xiao; Wen-Xuan Feng; Zi-Ping Li; Ling-Feng Zeng
Journal:  Front Endocrinol (Lausanne)       Date:  2022-02-18       Impact factor: 5.555

2.  Multitech-Based Study on Medicinal Material Basis and Action Mechanism of Herbal Formula Xian-Ling-Gu-Bao Capsule in Treatment of Osteoarthritis.

Authors:  Xiaowen Wu; Shuai Sun; Xiaoyi Wu; Zengxian Sun
Journal:  Evid Based Complement Alternat Med       Date:  2022-09-06       Impact factor: 2.650

3.  Exosomal miR-100-5p inhibits osteogenesis of hBMSCs and angiogenesis of HUVECs by suppressing the BMPR2/Smad1/5/9 signalling pathway.

Authors:  Wu Yang; Weiwen Zhu; Yunfei Yang; Minkang Guo; Husun Qian; Weiqian Jiang; Yu Chen; Chengjie Lian; Zijie Xu; Haobo Bai; Tingmei Chen; Jian Zhang
Journal:  Stem Cell Res Ther       Date:  2021-07-13       Impact factor: 6.832
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.